Abcam plc (LON:ABC – Get Free Report) shot up 11.2% during mid-day trading on Thursday . The company traded as high as GBX 1,259 ($16.05) and last traded at GBX 1,226 ($15.63). 6,372,291 shares traded hands during trading, an increase of 1,522% from the average session volume of 392,791 shares. The stock had previously closed at GBX 1,103 ($14.06).
Abcam Price Performance
The company has a debt-to-equity ratio of 31.60, a current ratio of 1.27 and a quick ratio of 0.89. The business’s 50 day moving average price is GBX 1,226 and its 200 day moving average price is GBX 1,226. The stock has a market capitalization of £2.81 billion and a P/E ratio of 20,433.33.
Abcam Company Profile
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools.
Recommended Stories
- Five stocks we like better than Abcam
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Fast-Growing Companies That Are Still Undervalued
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Top Cybersecurity Stock Picks for 2025
- EV Stocks and How to Profit from Them
- Archer or Joby: Which Aviation Company Might Rise Fastest?
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.